Data from Seoul National University Advance Knowledge in Urothelial Cancer (Phase Ii Study of a Trastuzumab Biosimilar In Combination With Paclitaxel for Her2-positive Recurrent or Metastatic Urothelial Carcinoma: Kcsg Gu18-18)

Press/Media: Press / Media

Period2023 Sept 28

Media coverage

1

Media coverage

  • TitleData from Seoul National University Advance Knowledge in Urothelial Cancer (Phase Ii Study of a Trastuzumab Biosimilar In Combination With Paclitaxel for Her2-positive Recurrent or Metastatic Urothelial Carcinoma: Kcsg Gu18-18)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date23/9/28
    PersonsHyun Kyu Song, June Choi, June Choi, Kyong Hwa Park, KyongHwa Park
View all 1
View less

Related content